Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Control of the Tumor Microenvironment
David L. Marks, Rachel Olson, Martín E. Fernández-Zapico
Epigenomics (2016) Vol. 8, Iss. 12, pp. 1671-1687
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 6, pp. 366-381
Open Access | Times Cited: 905
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 746
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K.G.K. Deepak, Rahul Kumar Vempati, Ganji Purnachandra Nagaraju, et al.
Pharmacological Research (2020) Vol. 153, pp. 104683-104683
Closed Access | Times Cited: 442
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Cédric Zeltz, Irina Primac, Pugazendhi M Erusappan, et al.
Seminars in Cancer Biology (2019) Vol. 62, pp. 166-181
Open Access | Times Cited: 242
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 125
Single cell cancer epigenetics
Marta Casado-Peláez, Alberto Bueno-Costa, Manel Esteller
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 820-838
Open Access | Times Cited: 77
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 55
Ex Vivo Tumor Culture Systems for Functional Drug Testing and Therapy Response Prediction
Titia G. Meijer, Kishan A.T. Naipal, Agnes Jager, et al.
Future Science OA (2017) Vol. 3, Iss. 2
Open Access | Times Cited: 140
The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
Dimakatso Alice Senthebane, Tina Jonker, Arielle Rowe, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2861-2861
Open Access | Times Cited: 127
The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome
Elisa D’Arcangelo, Nila C. Wu, Jose L. Cadavid, et al.
British Journal of Cancer (2020) Vol. 122, Iss. 7, pp. 931-942
Open Access | Times Cited: 98
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Cancer Genomics & Proteomics (2017) Vol. 14, Iss. 5
Open Access | Times Cited: 90
The evolving landscape of N6-methyladenosine modification in the tumor microenvironment
Yunru Gu, Xi Wu, Jingxin Zhang, et al.
Molecular Therapy (2021) Vol. 29, Iss. 5, pp. 1703-1715
Open Access | Times Cited: 87
Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3
Masahiro Maeda, Hideyuki Takeshima, Naoko Iida, et al.
Gut (2019) Vol. 69, Iss. 2, pp. 243-251
Closed Access | Times Cited: 80
Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
Jenniffer Linares, Juan A. Marín‐Jiménez, Jordi Badia-Ramentol, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 78
Identifying key questions in the ecology and evolution of cancer
Antoine M. Dujon, Athena Aktipis, Catherine Alix‐Panabières, et al.
Evolutionary Applications (2020) Vol. 14, Iss. 4, pp. 877-892
Open Access | Times Cited: 74
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator
Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access | Times Cited: 11
Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment
Antonio García-Gómez, Javier Rodríguez‐Ubreva, Esteban Ballestar
Clinical Immunology (2018) Vol. 196, pp. 64-71
Closed Access | Times Cited: 79
The role of histone deacetylase inhibitors in metastatic breast cancer
B Zucchetti, Andrea Kazumi Shimada, Artur Katz, et al.
The Breast (2018) Vol. 43, pp. 130-134
Closed Access | Times Cited: 60
Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix
Antônio Palumbo, Nathalia Meireles Da Costa, Bruno Pontes, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 455-455
Open Access | Times Cited: 51
Genome-wide DNA hypermethylation opposes healing in patients with chronic wounds by impairing epithelial-mesenchymal transition
Kanhaiya Singh, Yashika Rustagi, Ahmed S. Abouhashem, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 17
Open Access | Times Cited: 35
Aging and cancer epigenetics: Where do the paths fork?
Raúl F. Pérez, Juan Ramón Tejedor, Agustín F. Fernández, et al.
Aging Cell (2022) Vol. 21, Iss. 10
Open Access | Times Cited: 33
Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
Haixiang Pei, Weikai Guo, Yangrui Peng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1607-1660
Closed Access | Times Cited: 31
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Xingyi Pan, Lei Zheng
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 9, pp. 940-953
Open Access | Times Cited: 49
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Fabiana Crispo, Valentina Condelli, Silvia Lepore, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 798-798
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top